Coexisting JAK2V617F and CALR Exon 9 Mutation in Essential Thrombocythemia

about

Progenitor genotyping reveals a complex clonal architecture in a subset of CALR-mutated myeloproliferative neoplasms.

P2860

Q38717569-70198A88-35D8-4624-88B3-D8EA37700195

P2860

Coexisting JAK2V617F and CALR Exon 9 Mutation in Essential Thrombocythemia

Item

http://www.wikidata.org/entity/Q37048522

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 09 February 2016

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Coexisting JAK2V617F and CALR Exon 9 Mutation in Essential Thrombocythemia

@en

Coexisting JAK2V617F and CALR Exon 9 Mutation in Essential Thrombocythemia.

@nl

type

Item

label

Coexisting JAK2V617F and CALR Exon 9 Mutation in Essential Thrombocythemia

@en

Coexisting JAK2V617F and CALR Exon 9 Mutation in Essential Thrombocythemia.

@nl

prefLabel

Coexisting JAK2V617F and CALR Exon 9 Mutation in Essential Thrombocythemia

@en

Coexisting JAK2V617F and CALR Exon 9 Mutation in Essential Thrombocythemia.

@nl

P1476

Coexisting JAK2V617F and CALR Exon 9 Mutation in Essential Thrombocythemia

@en

P2093

Muhammad Nadeem

http://www.w3.org/2001/XMLSchema#string

Munazza Rashid

http://www.w3.org/2001/XMLSchema#string

Nuzhat Ahmed

http://www.w3.org/2001/XMLSchema#string

Rifat Zubair Ahmed

http://www.w3.org/2001/XMLSchema#string

Shariq Ahmed

http://www.w3.org/2001/XMLSchema#string

Tahir Sultan Shamsi

http://www.w3.org/2001/XMLSchema#string

P2860

Somatic CALR mutations in myeloproliferative neoplasms with nonmutated JAK2

Calreticulin (CALR) mutation in myeloproliferative neoplasms (MPNs)

CALR vs JAK2 vs MPL-mutated or triple-negative myelofibrosis: clinical, cytogenetic and molecular comparisons

Somatic mutations of calreticulin in myeloproliferative neoplasms.

Calreticulin exon 9 mutations in myeloproliferative neoplasms.

Incidence, clinical features, and prognostic impact of CALR exon 9 mutations in essential thrombocythemia and primary myelofibrosis: an experience of a single tertiary hospital in Korea.

Analysis of phenotype and outcome in essential thrombocythemia with CALR or JAK2 mutations.

An overview on CALR and CSF3R mutations and a proposal for revision of WHO diagnostic criteria for myeloproliferative neoplasms.

Calreticulin gene exon 9 frameshift mutations in patients with thrombocytosis.

Somatic mutations of calreticulin in a Brazilian cohort of patients with myeloproliferative neoplasms.

P2888

s12288-016-0658-y

P304

112-116

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

case report

P356

10.1007/S12288-016-0658-Y

http://www.w3.org/2001/XMLSchema#string

P433

Suppl 1

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-02-09T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27408370

http://www.w3.org/2001/XMLSchema#string

P932

4925557

http://www.w3.org/2001/XMLSchema#string

Coexisting JAK2V617F and CALR Exon 9 Mutation in Essential Thrombocythemia

about

P2860

P2860

Coexisting JAK2V617F and CALR Exon 9 Mutation in Essential Thrombocythemia

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P698

P932